|
Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers Clinical research trials and Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers. Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers clinical trial. Human subjects often obtain the finest healthcare possible for their Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers  Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers
Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers
For Condition: Rheumatic Diseases,Healthy
Status: Recruiting
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,
Synopsis: This study will collect white blood cells or plasma (the liquid part of the blood), or both, from healthy volunteers and from patients with rheumatic disorders for research purposes. Rheumatic disorders involve abnormalities of the immune system, the body's defense against disease. The immune system consists of white blood cells such as lymphocytes and monocytes, which produce substances such as antibodies and cytokines. White cells and plasma will be collected through a procedure called apheresis (described below). Healthy volunteers and patients with confirmed or suspected rheumatic disease who are 18 years of age or older may be eligible for this study. Patients must be participating in a current protocol of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. All candidates will be screened with a history, physical examination, and blood tests for hepatitis B and C and HIV infection. Women of childbearing age will be tested for pregnancy. Routine blood tests will be done in all volunteers, and in patients where needed. Pregnant women and people who test positive for hepatitis or HIV may not participate. Participants will undergo apheresis to collect lymphocytes, monocytes, or plasma from the blood. For this procedure, a needle is placed in a vein in the arm. Blood flows from the vein through a tube (catheter) into a machine that spins the blood, separating it into its components. The required cells or plasma are extracted, and the rest of the blood, including the red cells and platelets, is returned to the body through the same needle or through a second needle placed in the other arm. Cells collected from volunteers will be used in studies comparing the number and function of similar cells from patients with rheumatic diseases, focusing on the differences in number and function of the cells in health and disease. Components collected from patients will be used only for studies described in the protocol in which they are currently enrolled.
Details: Blood components will be collected using apheresis from normal volunteers and patients with rheumatic diseases. Mononuclear cells and plasma will be used by various investigators for research studies.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA - Subjects with Rheumatic Diseases: Patients with a diagnosed or suspected rheumatic disease, who are actively involved in a NIAMS protocol (have a current, signed consent form) Ability to give informed consent Age greater than or equal to 18 years EXCLUSION CRITERIA - Subjects with Rheumatic Diseases: History of allergy to acid-citrate-dextrose (ACD) anticoagulant History of bleeding diatheses Hemoglobin less than 9.0 g/dL Platelet count less than 50,000/mm(3) Pregnancy Inadequate peripheral venous access Active hepatitis B, C and/or HIV infection Symptomatic coronary artery or valvular heart disease Any concomitant illness that in the opinion of the investigators will substantially increase risk of apheresis. INCLUSION CRITERIA - Healthy Volunteers: Subjects shall meet all donor eligibility criteria for autologous blood donation recommended or required by the Standards of the American Association of Blood Banks (1) and the Code of Federal Regulations of the Food and Drug Administration (2), with the exception of the travel exclusions related to malaria exposure and hypothetical exposure to the agent of variant Creutzfeldt-Jacob disease. Ability to give informed consent Age greater than or equal to 18 years EXCLUSION CRITERIA - Healthy Volunteers: History of autoimmune or chronic rheumatic disease within the last 5 years, with the exception of osteoarthritis Active hepatitis B, C, and/or HIV infection History of allergy to acid-citrate (ACD) anticoagulant History of coagulopathies and bleeding diatheses Symptomatic coronary artery disease or valvular heart disease Hemoglobin less than 12.0 g/dL Platelet count less than 100,000/cubic mm Pregnancy Inadequate peripheral venous access Any concomitant illness that in the opinion of the investigators will substantially increase the risk of apheresis or make the volunteer ineligible for study controls are needed for (eg: active infection, allergies, etc.)
Total Enrollment: 9999
Location and Contact Information:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 020131; 02-AR-0131
Study Start Date: February 21, 2002
Record last reviewed: January 21, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00031174
Other Rheumatic Diseases Studies:
1. 41.8 degree Centigrade whole body hyperthermia for the treatment of Rheumatoid diseases
2. Improving Vocational Outcomes in Arthritis
3. Study of Families with Twins or Siblings Discordant for Rheumatic Disorders
4. Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers
5. Health Beliefs and Health Behaviors Among Minorities with Rheumatic Diseases
Related Studies:
Other Rheumatic Diseases Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers
|
|
|
|
|
|
|
|
